Market Share of Global Treatment-Resistant Depression Industry
The Treatment- Resistant Depression market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are AstraZeneca, Pfizer, Inc, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb Company, Forest Laboratories, Johnson and Johnson, Schering Plough Corporation, Vistagen Therapeutics, Inc, Wyeth, and Others
Treatment-Resistant Depression Market Leaders
-
AstraZeneca
-
Pfizer
-
GlaxoS
-
Eli Lilly and Company
-
Johnson and Johnson
*Disclaimer: Major Players sorted in no particular order
